5tdi_cathepsinK_odanacatib.png (800 × 600 pixels, file size: 266 KB, MIME type: image/png)
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 06:35, 28 December 2021 |
![]() | 800 × 600 (266 KB) | Opabinia regalis | {{Information |Description=The X-ray crystallography structure of human cathepsin K in complex with the covalent inhibitor odanacatib, shown in light blue with covalently modified catalytic cysteine in green. Odanacatib was studied in clinical trials as a cathepsin K inhibitor for osteoporosis. Rendered with PyMol from {{PDB|5TDI}}. Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib. Law, S., Andrault, P.M., Aguda, A.H., Nguyen, N.T., Kruglyak, N.... |
5tdi_cathepsinK_odanacatib.png (800 × 600 pixels, file size: 266 KB, MIME type: image/png)
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 06:35, 28 December 2021 |
![]() | 800 × 600 (266 KB) | Opabinia regalis | {{Information |Description=The X-ray crystallography structure of human cathepsin K in complex with the covalent inhibitor odanacatib, shown in light blue with covalently modified catalytic cysteine in green. Odanacatib was studied in clinical trials as a cathepsin K inhibitor for osteoporosis. Rendered with PyMol from {{PDB|5TDI}}. Identification of mouse cathepsin K structural elements that regulate the potency of odanacatib. Law, S., Andrault, P.M., Aguda, A.H., Nguyen, N.T., Kruglyak, N.... |